Carcinoma, Pancreatic Ductal
"Carcinoma, Pancreatic Ductal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Descriptor ID |
D021441
|
| MeSH Number(s) |
C04.557.470.200.025.232.750 C04.557.470.615.132.750 C04.588.274.761.750 C04.588.322.475.750 C06.301.761.750 C06.689.667.625 C19.344.421.750
|
| Concept/Terms |
Carcinoma, Pancreatic Ductal- Carcinoma, Pancreatic Ductal
- Carcinomas, Pancreatic Ductal
- Ductal Carcinoma, Pancreatic
- Ductal Carcinomas, Pancreatic
- Pancreatic Ductal Carcinomas
- Duct-Cell Carcinoma of the Pancreas
- Duct Cell Carcinoma of the Pancreas
- Pancreatic Ductal Carcinoma
- Ductal Carcinoma of the Pancreas
- Pancreatic Duct Cell Carcinoma
- Carcinoma, Ductal, Pancreatic
- Duct-Cell Carcinoma, Pancreas
- Carcinoma, Pancreas Duct-Cell
- Carcinomas, Pancreas Duct-Cell
- Duct Cell Carcinoma, Pancreas
- Duct-Cell Carcinomas, Pancreas
- Pancreas Duct-Cell Carcinoma
- Pancreas Duct-Cell Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Pancreatic Ductal".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Ductal [C04.557.470.200.025.232]
- Carcinoma, Pancreatic Ductal [C04.557.470.200.025.232.750]
- Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
- Carcinoma, Ductal [C04.557.470.615.132]
- Carcinoma, Pancreatic Ductal [C04.557.470.615.132.750]
- Neoplasms by Site [C04.588]
- Digestive System Neoplasms [C04.588.274]
- Pancreatic Neoplasms [C04.588.274.761]
- Carcinoma, Pancreatic Ductal [C04.588.274.761.750]
- Endocrine Gland Neoplasms [C04.588.322]
- Pancreatic Neoplasms [C04.588.322.475]
- Carcinoma, Pancreatic Ductal [C04.588.322.475.750]
- Digestive System Diseases [C06]
- Digestive System Neoplasms [C06.301]
- Pancreatic Neoplasms [C06.301.761]
- Carcinoma, Pancreatic Ductal [C06.301.761.750]
- Pancreatic Diseases [C06.689]
- Pancreatic Neoplasms [C06.689.667]
- Carcinoma, Pancreatic Ductal [C06.689.667.625]
- Endocrine System Diseases [C19]
- Endocrine Gland Neoplasms [C19.344]
- Pancreatic Neoplasms [C19.344.421]
- Carcinoma, Pancreatic Ductal [C19.344.421.750]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Pancreatic Ductal".
This graph shows the total number of publications written about "Carcinoma, Pancreatic Ductal" by people in this website by year, and whether "Carcinoma, Pancreatic Ductal" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2008 | 4 | 0 | 4 | | 2009 | 3 | 1 | 4 | | 2010 | 2 | 1 | 3 | | 2011 | 4 | 0 | 4 | | 2012 | 1 | 0 | 1 | | 2013 | 5 | 2 | 7 | | 2014 | 6 | 0 | 6 | | 2015 | 9 | 1 | 10 | | 2016 | 11 | 1 | 12 | | 2017 | 9 | 2 | 11 | | 2018 | 9 | 1 | 10 | | 2019 | 12 | 2 | 14 | | 2020 | 8 | 1 | 9 | | 2021 | 11 | 0 | 11 | | 2022 | 15 | 0 | 15 | | 2023 | 18 | 0 | 18 | | 2024 | 17 | 5 | 22 | | 2025 | 18 | 1 | 19 | | 2026 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Pancreatic Ductal" by people in Profiles.
-
O'Connor TN, Schultz E, Horowitz M, Alexander MH, Fountzilas C, Cherkassky L, Onel K, Knudsen ES, Witkiewicz AK. Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study. JCO Precis Oncol. 2026 Apr; 10(4):e2501088.
-
Holmberg M, Dall'Olio T, Marwa M, Hansen CP, Kleive DB, Nappo G, Shi L, Sandström P, Björk D, Hadesi P, De Rosa RV, Andersson B, Ansari D, Chikkala B, Todeschini L, Leseman C, Schuitema J, Lodewijks Y, Månsson C, Delis S, Berrevoet F, Giannone F, Xenaki S, Pando E, Bertrand C, Vasileiadis K, Kirchweger P, Ciulla C, Luchini C, Luyer M, Besselink MG, Marchegiani G, Pandanaboyana S, Tingstedt B, Sulpice L, Wennerblom J, Björnsson B, Balakrishnan A, Labori KJ, Burgdorf SK, Qadan M, Sparrelid E, Pea A, Hernandez-Barco YG, Salvia R, Ghorbani P. Survival After Pancreatic Resection for Intraductal Papillary Mucinous Neoplasm: Supporting Selective Surgery. United European Gastroenterol J. 2026 Apr; 14(3):e70199.
-
Torborg SR, Kim JY, Singhal A, Grbovic-Huezo O, Holm M, Wu K, Han X, Ho YJ, Haglund C, Mitchell MJ, Lowe SW, Dow LE, Pitter KL, Sanchez-Rivera FJ, Levchenko A, Tammela T. Disruption of WNT/Notch signaling in pancreatic cancer reveals tumors depend on the intricate equilibrium of malignant cell states. Dev Cell. 2026 May 13; 61(5):1012-1027.e8.
-
Tsybulskyi D, Hashimoto D, Tanaka K, Murotani K, Taguri M, Yamaki S, Sato S, Oba A, Inoue Y, Otsuka S, Ohgi K, Sugiura T, Shintakuya R, Okada K, Uemura K, Inoue K, Mizuma M, Unno M, Asano T, Nakagawa N, Takami H, Takahashi R, Motoi F, Akahoshi K, Ban D, Gulla A, Ishikawa H, Hirano S, Satoi S. Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model. J Hepatobiliary Pancreat Sci. 2026 Mar; 33(3):216-227.
-
Aaquist T, Henriksen TV, Mariager Jakobsen LL, Fristrup CW, Pfeiffer P, de Stricker K, Sparrelid E, Moro CF, Mortensen F, Knudsen AR, Hamilton-Dutoit S, Kleeff J, Mortensen MB, Andersen CL, Detlefsen S. Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. Hum Pathol. 2026 Feb; 168:106024.
-
Miyata T, Oba A, Kato T, Maekawa A, Tsuchiya S, Baba H, Tauchi J, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Iwatsuki M, Matsueda K, Inoue Y, Takahashi Y. Surgical Challenges Associated with Collateral Veins Formation in Pancreatic Cancer with Vein Resection. Ann Surg Oncol. 2026 Apr; 33(4):3535-3544.
-
Akinlalu A, Rasuleva K, Ogberefor E, Gao T, Han H, Singh PK, Lieu CH, Coughlan C, Pitts TM, Sun D. A Fluorescence Resonance Energy Transfer-Based Assay Targeting Tumor-Derived Extracellular Vesicles for Highly Specific Pancreatic Cancer Detection. ACS Nano. 2025 Dec 23; 19(50):42056-42065.
-
Bryant JM, Shotbolt M, Stimphil E, Andre V, Zhang E, Estrella V, Husain K, Weygand J, Marchion D, Lopez AS, Abrahams D, Chen S, Abdel-Mottaleb M, Conlan S, Oraiqat I, Khatri V, Guevara JA, Pilon-Thomas S, Redler G, Latifi K, Raghunand N, Yamoah K, Hoffe S, Costello J, Frakes JM, Liang P, Gatenby RA, Malafa M, Khizroev S. Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models. Adv Sci (Weinh). 2026 Feb; 13(9):e17228.
-
Ishida H, Rodriguez Franco S, Franklin O, Fujiwara Y, Khomiak A, Balmaceda NB, Pellegrini R, Mungo B, Schulick RD, Del Chiaro M. Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2026 Mar; 33(3):2620-2631.
-
Ishida J, Franklin O, Franco SR, Ishida H, Khomiak A, Sugawara T, Grandi S, Stoop TF, Kirsch MJ, Schulick RD, Del Chiaro M. Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancer. HPB (Oxford). 2026 Mar; 28(3):369-378.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|